|
| Exchange Received Time 24/09/2018 18:50:53 Exchange Disseminated Time 24/09/2018 18:50:59 Time Taken 00:00:06 | Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we wish to inform you that our material wholly-owned subsidiary, Jubilant Pharma Limited (a company incorporated under the laws of Singapore) ('JPL') proposes to organise exploratory meetings with one or more international institutional investors located in different jurisdictions, between September 25, 2018 and November 30, 2018, in connection with JPL's proposed plan of fund raising.
The schedule may undergo change due to exigencies on the part of the investors or JPL.
A copy of the investor presentation to be shared with investors during the meetings is attached herewith. Further, the investor presentation along with certain related additional information shall also be available on the website of the Company (www.jubl.com).
The Company will provide further updates in this regard, if and when necessary. |
|
|